The NICE/DSU/ABPI Masterclasses are unique in being focused solely on the specific requirements of NICE and its Appraisal Committees and on the challenges associated with key areas of evidence generation and methodology. They are specifically designed for staff in pharmaceutical companies who prepare submissions, the consultancies that support them, and members of the academic groups who review submissions.
Park Plaza County Hall London
1 Addington Street
Wednesday 21 November 2018
9:30 - 17:00
This masterclass ‘Using non-randomised data to estimate treatment effects in NICE submissions’ covers an increasingly important area of methodology and has been developed for those who are currently involved in developing submissions to the NICE technology appraisals programme. It is suitable for those who are familiar with economic evaluation and the requirements of the NICE Guide to the Methods of Technology Appraisal. It does not require any specific statistical knowledge but will assume that attendees are familiar with simple concepts like regression.
This masterclass is an opportunity to hear directly from members of the NICE Decision Support Unit and other leading HTA experts on:
All sessions will consist of a formal presentation followed by small groups discussions centred around real-life examples. The day will also include information on the NICE Observational Data Unit.REGISTER NOW